rs111903796
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000320393.9(BCKDHB):c.742+7A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,510,058 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000320393.9 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCKDHB | NM_183050.4 | c.742+7A>T | splice_region_variant, intron_variant | ENST00000320393.9 | NP_898871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCKDHB | ENST00000320393.9 | c.742+7A>T | splice_region_variant, intron_variant | 1 | NM_183050.4 | ENSP00000318351 | P1 | |||
BCKDHB | ENST00000356489.9 | c.742+7A>T | splice_region_variant, intron_variant | 1 | ENSP00000348880 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00169 AC: 256AN: 151782Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000479 AC: 113AN: 235840Hom.: 0 AF XY: 0.000429 AC XY: 55AN XY: 128204
GnomAD4 exome AF: 0.000190 AC: 258AN: 1358156Hom.: 2 Cov.: 21 AF XY: 0.000181 AC XY: 123AN XY: 680380
GnomAD4 genome AF: 0.00174 AC: 264AN: 151902Hom.: 1 Cov.: 32 AF XY: 0.00184 AC XY: 137AN XY: 74278
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 26, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Maple syrup urine disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at